Slingshot members are tracking this event:

Phase 2/3 data of Biohaven's (BHVN) TRORILUZOLE in Generalized anxiety disorder (GAD) due early-1Q 2020

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
BHVN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2020
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Troriluzole, Anxiety Disorders, Generalized Anxiety Disorder